Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

8:05 AM ET 8-K
Licensing Deal Netlist Inc NLST

Netlist Licensing Deal with Micron Technology, Inc Worth $600M

Netlist entered into a five-year patent license and settlement agreement with Micron Technology, resolving all pending legal proceedings between the companies. Micron will pay Netlist $30 million per quarter through Q3 2031, totaling $600 million, and will also purchase 10 million shares of Netlist common stock for $1 million.

Value
$600M
Counterparty
Micron Technology, Inc
Term
5 years
8:04 AM ET 8-K
M&A Deal Mckesson Corp MCK

Mckesson Signs $5.8B M&A Deal with Option Care Health, Inc.

McKesson Corporation and Clayton, Dubilier & Rice (CD&R) have entered into a definitive agreement to acquire Option Care Health for $32.05 per share, representing a total enterprise value of approximately $5.8 billion. Upon closing, CD&R will hold a majority stake while McKesson will hold a minority interest in the home and alternate site infusion services provider. The deal aligns with McKesson's strategy to expand access to innovative therapies in lower-cost community and home settings.

Value
$5.8B
Counterparty
Option Care Health, Inc.
8:01 AM ET 8-K
Capital Raise Telomir Pharmaceuticals, Inc. TELO

Telomir Pharmaceuticals Capital Raise of $5.6M

Telomir Pharmaceuticals raised approximately $5.6 million in a PIPE financing through the issuance of 4,843,300 shares of common stock at $1.16 per share. The offering included a $1.0 million investment from existing shareholder John Paul DeJoria and will be used to fund the clinical development of Telomir-Zn for triple-negative breast cancer.

Value
$5.6M
Counterparty
John Paul DeJoria

“I have always looked for opportunities that can do the greatest good for the greatest number of people, and that is part of what attracted me to Telomir. Cancer continues to take an enormous toll on patients and families, and there remains a need for new approaches that can potentially improve the way we treat this disease. Telomir is pursuing a different scientific approach, and with the Company now moving into human clinical trials, I am pleased to increase my investment and support the team as they work to determine what Telomir-Zn may be able to do for patients.”

John Paul DeJoria

“We have been very deliberate about how and when we access the capital markets. Our strategy is to raise capital around meaningful milestones, deploy it toward value-driving objectives and progressively de-risk the program, while remaining mindful of our existing shareholders. As Telomir enters clinical development, our focus is on execution: deploying this capital efficiently to advance Telomir-Zn through its Phase 1/2 clinical program, generate meaningful human data and position the Company strongly for the milestones ahead.”

Erez Aminov, Chairman and CEO
8:00 AM ET 8-K
Contract Win Boost Run Inc. BRUN

Boost Run Wins $526M Contract from Cohere Inc

Boost Run Inc.'s subsidiary entered into a material service agreement with Cohere Inc to provide dedicated GPU cloud computing infrastructure and related services. Cohere has committed to pay approximately $525.6 million over a five-year term, with infrastructure delivery expected to begin in the second quarter of 2027.

Value
$526M
Counterparty
Cohere Inc
Term
5 years
8:00 AM ET 8-K
Partnership Evolution Metals & Technologies Corp. EMAT

Evolution Metals & Technologies Partnership with INERGX Energy Optimisation Ltd.

Evolution Metals & Technologies Corp. (EM&T) entered into a Strategic Partnership Letter of Intent with UK-based INERGX to engineer and service energy storage systems for EM&T's planned critical materials facility in the U.S. The partnership includes a non-China supply mandate for battery components and a 10-year anticipated service term. The facility is planned to reach up to 5 GW of on-site capacity at full build-out, powered by on-site LNG generation.

Counterparty
INERGX Energy Optimisation Ltd.
Term
10 years
8:00 AM ET 8-K
Divestiture OFS Capital Corp OFS

OFS Capital Divestiture to New Investor for $52.3M

OFS Capital Corporation's subsidiary, SBIC I LP, admitted a third-party investor who acquired a 56.62% limited partnership interest for $52.3 million. SBIC I LP holds a significant stake in Pfanstiehl Holdings, Inc., and the proceeds will be used by the company to fund new investments and for general corporate purposes.

Value
$52.3M
Counterparty
New Investor
7:52 AM ET 8-K
Research Collaboration Regeneron Pharmaceuticals, Inc. REGN

Regeneron Pharmaceuticals Research Collaboration with Sanofi Worth $1B

Regeneron and Sanofi entered into a Sixth Amendment to their existing Antibody LCA to co-develop and co-commercialize four new long-acting antibodies targeting IL-13, IL-4, and IL-4Rα. Sanofi will pay Regeneron an upfront payment of $1.0 billion and up to $7.0 billion in potential development, regulatory, and commercial milestones, with global profits and development costs shared equally.

Value
$1B
Counterparty
Sanofi
7:30 AM ET 8-K
Clinical Trial Data Kairos Pharma, LTD. KAPA

Kairos Pharma Clinical Trial Data

Kairos Pharma reported positive interim efficacy data from its Phase 2 trial of ENV-105 (carotuximab) in combination with apalutamide for metastatic castration-resistant prostate cancer. The combination therapy demonstrated a statistically significant median progression-free survival of 17.7 months compared to 2 months for apalutamide alone (P=0.0008). Based on these results, the company has modified the trial protocol to enroll patients earlier in the disease progression and targets trial completion by Q4 2027.

7:25 AM ET 8-K
Capacity Expansion Professional Diversity Network, Inc. IPDN

Professional Diversity Network Capacity Expansion: $1.18M Investment

Professional Diversity Network's subsidiary, PDN Intelligence, committed $1.177 million to acquire and finance two NVIDIA B300 GPU systems, marking its initial entry into AI computing infrastructure. The company is leasing one system to Goodwill Labs and providing a secured loan for a second system, with operations supported by technical partner HashForest. This move represents a strategic shift from planning to execution in the company's AI infrastructure business.

Value
$1.18M
Counterparty
Goodwill Labs Inc.
Term
60 months

“We are moving from strategy to execution. By placing our initial order and committing capital toward next-generation AI computing infrastructure, we are establishing the foundation for PDN Intelligence’s operations.”

Yiran Gu, Chief Executive Officer and Chief Financial Officer

“We believe demand for advanced computing capacity will continue to create opportunities across the AI ecosystem. Our approach is to begin with disciplined infrastructure deployment, establish operating capabilities and evaluate future expansion based on market demand, utilization and economics.”

Yiran Gu, Chief Executive Officer and Chief Financial Officer
7:15 AM ET 8-K
M&A Deal Indivior Pharmaceuticals, Inc. SUPN

Indivior Pharmaceuticals M&A Deal with Supernus Pharmaceuticals, Inc.

Indivior Pharmaceuticals, Inc. provided a status update on its pending merger with Supernus Pharmaceuticals, Inc., specifically addressing supplemental disclosures to the joint proxy statement/prospectus. The update follows demand letters and complaints from Supernus stockholders alleging disclosure deficiencies, which the company believes are meritless but is addressing to avoid litigation risk. The special meetings for stockholders of both companies to vote on the merger are scheduled for October 15, 2026.

Counterparty
Supernus Pharmaceuticals, Inc.
6:31 AM ET 8-K
Divestiture Barnwell Industries Inc BRN

Barnwell Industries Divestiture to 2798913 Alberta Ltd.

Barnwell Industries has entered into a definitive agreement to sell its Canadian oil and natural gas business to 2798913 Alberta Ltd. for a base purchase price of C$9,000,000. The consideration includes C$4,000,000 in cash and a 5% gross overriding royalty on future wells (valued at C$5,000,000), which the buyer has an option to buy out for an additional C$5,000,000.

Counterparty
2798913 Alberta Ltd.
6:15 AM ET 8-K
Capital Raise HighPeak Energy, Inc. HPK

HighPeak Energy Capital Raise of $450M

HighPeak Energy entered into agreements to raise $450 million through the private placement of 450,000 shares of newly created Series A 6.0% Perpetual Convertible Preferred Stock to subsidiaries of PT Danantara Investment Management and PT Energi Mega Persada Tbk. The proceeds, combined with a new $800 million reserve-based credit facility, will be used to refinance and repay the company's existing $1.17 billion term loan in full.

Value
$450M
Counterparty
PT Danantara Energy International and PT Tunas Harapan Perkasa

“Today marks a milestone for HighPeak Energy. This comprehensive refinancing will materially strengthen our balance sheet, significantly reduce our financing burden and enhance our ability to generate long-term value for shareholders. The combination of permanent capital from high-quality investors alongside a new reserve-based lending facility will enable HighPeak to retire its existing term loan and establish a much more effective capital structure.”

Michael Hollis, President and Chief Executive Officer

“We expect that this transaction will improve our liquidity profile, materially reduce our annual interest expense, and provide us with greater financial flexibility to focus on disciplined development, free cash flow generation and continued shareholder value creation.”

Michael Hollis, President and Chief Executive Officer
6:03 AM ET 8-K
Contract Win Artificial Intelligence Technology Solutions Inc. AITX

Artificial Intelligence Technology Solutions Wins Contract from Global Logistics Client

AITX's subsidiary, Robotic Assistance Devices (RAD), has secured an order for a third ROAMEO autonomous security patrol vehicle from a global logistics client. The vehicle will be deployed at a cosmetics manufacturer's site to replace or augment manned security patrols, with delivery expected by the end of 2026.

Counterparty
Global Logistics Client
6:01 AM ET 8-K
Divestiture Adia Med, Inc. ADIA

Adia Med Divestiture to Live Oak Health LLC for $1.5M

Adia Med, Inc. entered into a Membership Interest Purchase Agreement to sell a 30% interest in its subsidiary, Adia Labs LLC, to Live Oak Health LLC (dba QCM Biologics) for $1.5 million. The consideration consists of $1.0 million in cash and a $0.5 million promissory note, with the buyer also receiving an option to purchase an additional 10% stake for $0.5 million. Despite the minority equity sale, the agreement establishes equal 50/50 voting power between Adia Med and the buyer regarding member matters.

Value
$1.5M
Counterparty
Live Oak Health LLC
5:27 PM ET 8-K
Divestiture Reliance Global Group, Inc. XGPU

Reliance Global Group Divestiture for $8M

Reliance Global Group completed the sale of its Altruis Benefit Consulting subsidiary for $8 million in cash plus a potential $1 million earnout. The transaction is part of the company's portfolio monetization strategy to divest non-core assets and redeploy capital into its proprietary AI platform and RELI Exchange network.

Value
$8M
Term
3 years
5:22 PM ET 8-K
Divestiture Firy Inc. FIRY

Firy Divestiture to Exit Games GmbH for $55M

Firy Inc. completed the sale of its entire 10.5% equity stake in Hamburg-based developer Exit Games GmbH back to the counterparty for $55 million in cash. The transaction represents a fully realized cash exit from a 2021 investment, providing the company with increased balance sheet liquidity and optionality.

Value
$55M
Counterparty
Exit Games GmbH
5:21 PM ET 8-K
M&A Deal Novagold Resources Inc NG

Novagold Resources M&A Deal with Paulson Advisers LLC

NOVAGOLD has filed and commenced mailing proxy materials for a special meeting on November 3, 2026, to approve the acquisition of the remaining 40% interest in Donlin Gold LLC from Paulson Advisers LLC. The all-share transaction will increase NOVAGOLD's ownership of the Donlin Gold project in Alaska from 60% to 100% and involve a re-domestication to Delaware.

Counterparty
Paulson Advisers LLC
5:20 PM ET 8-K
Capital Raise UWM Holdings Corp UWMC

UWM Holdings Capital Raise of $400M

UWM Holdings Corporation has commenced a $400 million rights offering, allowing existing Class A stockholders to purchase shares at a subscription price of at least $2.00 per share. The offering is supported by a backstop agreement from CEO Mat Ishbia and Oaktree Capital Management, ensuring the company raises the full $400 million regardless of shareholder participation. Proceeds will be used for general corporate purposes, with the rights offering set to expire on November 12, 2026.

Value
$400M
Counterparty
Oaktree Capital Management, L.P.
Term
through Nov 12, 2026
5:07 PM ET 8-K
Licensing Deal Aviat Networks, Inc. AVNW

Aviat Networks Licensing Deal with Dixon Electro Appliances Private Ltd.

Aviat Networks, through its subsidiary, entered into an intellectual property license agreement with Dixon Electro Appliances Private Ltd. (DEAPL) to manufacture and sell WTM 4000 microwave radios in India. The partnership allows Aviat to address the 'Made in India' market requirements while retaining its IP and providing software and services, targeting an estimated demand of 250,000 links over the next four years.

Counterparty
Dixon Electro Appliances Private Ltd.
5:07 PM ET 8-K
Regulatory Approval Equillium, Inc. EQ

Equillium Regulatory Approval

Equillium received clearance from the Therapeutic Goods Administration in Australia under the Clinical Trial Notification scheme to initiate a Phase 1 clinical trial of EQ504. The study will evaluate the safety and pharmacokinetics of the oral drug in healthy participants, with dosing expected to begin in early November 2026.

5:03 PM ET 8-K
Capital Raise Apollo IG Core Replacement, L.P.

Apollo IG Core Replacement Capital Raise of $3M

Apollo IG Core Replacement, L.P. issued unregistered limited partnership interests for approximately $3.0 million in cash on October 1, 2026. The sale was conducted as part of the fund's continuous private offering. Additionally, the company reported a net asset value (NAV) of $1,317.2 million as of August 31, 2026.

Value
$3M
5:03 PM ET 8-K
M&A Deal Fathom Holdings Inc. FTHM

Fathom Holdings M&A Deal with Neighborhood Intelligence, Inc.

Fathom Holdings and Neighborhood Intelligence (formerly Bed Bath & Beyond) have mutually agreed to terminate their previously announced merger agreement, citing that current market valuations do not reflect the fair value of either company. No termination fees will be owed by either party, and the companies intend to explore future strategic collaborations such as data sharing. Additionally, Fathom extended the maturity date of its senior secured convertible promissory notes to November 1, 2026, and lowered the conversion price to $0.65 per share.

Counterparty
Neighborhood Intelligence, Inc.
5:02 PM ET 8-K
Capital Raise John Hancock Comvest Private Income Fund

John Hancock Comvest Private Income Fund Capital Raise of $2B

John Hancock Comvest Private Income Fund is conducting a continuous public offering of up to $2.0 billion in common shares. As of August 31, 2026, the Fund reported an aggregate NAV of approximately $515.1 million and a debt-to-equity ratio of 0.91x. Additionally, the Fund assumed a JPMorgan credit facility following its acquisition of Manulife Private Credit Fund.

Value
$2B
5:01 PM ET 8-K
Contract Win NRX Pharmaceuticals, Inc. NRXP

NRX Pharmaceuticals Wins $11.2M Contract from Defense Advanced Research Projects Agency

NRx Defense Systems, a subsidiary of NRx Pharmaceuticals, was awarded an $11.2 million prime contract from DARPA to conduct the SPARC-TMS clinical trial. The trial evaluates a single-day treatment protocol combining robotic neuro-navigated transcranial magnetic stimulation with the company's investigational drug, NRX-101, for treatment-resistant depression. The contract includes an initial obligation of $6.7 million with additional funding subject to appropriations and performance milestones.

Value
$11.2M
Counterparty
Defense Advanced Research Projects Agency (DARPA)
Term
18 months
5:01 PM ET 8-K
M&A Deal Non Invasive Monitoring Systems Inc NIMU

Non Invasive Monitoring Systems Signs $125M M&A Deal with Gravitics, Inc.

Non-Invasive Monitoring Systems entered into a third amendment to its merger agreement with Gravitics, Inc., extending the closing deadline to October 30, 2026. The amendment significantly increases the target size of the associated underwritten public offering from $40 million to $125 million and modifies debt repayment terms for company affiliates. Additionally, the company extended the maturity of an $809,705 convertible note to align with the new merger timeline.

Value
$125M
Counterparty
Gravitics, Inc.
4:55 PM ET 8-K
M&A Deal Evernorth Holdings Inc. XRPN

Evernorth Holdings M&A Deal with Armada Acquisition Corp. II

Evernorth Holdings Inc. provided a status update on its pending business combination with Armada Acquisition Corp. II regarding an amendment to Armada II's existing warrant agreement. The amendment aligns the warrant exercise period with the terms originally disclosed in the IPO prospectus, making them exercisable 12 months after the IPO or upon the closing of the merger. The transaction will result in Evernorth becoming a publicly traded digital asset treasury focused on XRP exposure.

Counterparty
Armada Acquisition Corp. II
4:55 PM ET 8-K
M&A Deal Novagold Resources Inc NG

Novagold Resources M&A Deal with Paulson Advisers LLC

NOVAGOLD Resources Inc. provided a status update on its previously announced merger and reorganization into a new Delaware corporation, New NovaGold. Under the definitive agreements, New NovaGold will acquire all outstanding shares of the company and the 40% interest in the Donlin Gold project currently held by Paulson Advisers LLC, resulting in New NovaGold owning 100% of the project. The transaction remains subject to shareholder, court, and regulatory approvals.

Counterparty
Paulson Advisers LLC
4:51 PM ET 8-K
Capital Raise Macquarie Infrastructure Income Opportunities Fund

Macquarie Infrastructure Income Opportunities Fund Capital Raise of $7.39M

Macquarie Infrastructure Income Opportunities Fund raised $7.39 million in aggregate consideration through the sale of 290,031.399 Class J common shares in its September 2026 monthly closing. The shares were issued at a price of $25.48 per share, which was the fund's net asset value as of August 31, 2026. The offering was conducted as a continuous private placement exempt from registration requirements.

Value
$7.39M
4:48 PM ET 8-K
Partnership Grayscale Sui Staking ETF GSUI

Grayscale Sui Staking ETF Partnership with Anchorage Digital Bank N.A.

Grayscale Sui Staking ETF entered into an amendment to a Master Custody Service Agreement to add Anchorage Digital Bank N.A. as an additional custodian for the Trust's SUI holdings. This move is part of the Sponsor's risk management strategy to diversify custody providers alongside its primary custodian, Coinbase Custody Trust Company, LLC. Anchorage Digital will provide safekeeping services for a portion of the Trust's digital assets and maintain insurance coverage of at least $100 million.

Counterparty
Anchorage Digital Bank N.A.
4:46 PM ET 8-K
Bankruptcy & Restructuring Leslie's, Inc. LESLQ

Leslie's Bankruptcy & Restructuring

Leslie’s, Inc. and its subsidiaries filed voluntary Chapter 11 bankruptcy petitions in the Southern District of Texas to implement a pre-arranged reorganization plan. In connection with the filing, the company entered into debtor-in-possession (DIP) financing agreements consisting of a $90 million term loan facility and a $225 million asset-based revolving credit facility to support operations during the restructuring.

Counterparty
Consenting Term Loan Lenders

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.